Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
This study has been completed.
Study NCT00601016.   Last updated on January 24, 2008.
Information provided by St. Justine's Hospital
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemangioma, Capillary
Additional conditions recognized in this trial
Hemangioma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Vascular Tissue
Interventions listed in this trial
Imiquimod 5% cream
Additional drug interventions recognized in this trial
Imiquimod
More general drug interventions related to this trial
Adjuvants, Immunologic
Antineoplastic Agents
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Justine's Hospital
Graceway Pharmaceuticals, LLC


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services